The U.S. Vaccine Adjuvants Market is projected to grow from USD 0.62 Billion in 2025 to USD 1.61 Billion by 2035, while Europe is expected to expand from USD 1.08 Billion to USD 1.67 Billion, supported by rising investments in mRNA vaccines, oncology vaccines, and next-generation immunization technologies.
The U.S. Vaccine Adjuvants Market is projected to grow from USD 0.62 Billion in 2025 to USD 1.61 Billion by 2035, while Europe is expected to expand from USD 1.08 Billion to USD 1.67 Billion, supported by rising investments in mRNA vaccines, oncology vaccines, and next-generation immunization technologies.